Kunming Longjin Pharmaceutical Co Ltd Capital Reinvestment Ratio
Kunming Longjin Pharmaceutical Co Ltd capital reinvestment ratio. Kunming Longjin Pharmaceutical Co Ltd (002750) has a Capital Reinvestment Ratio of 6.23x as of December 2022, meaning it reinvests 6% of its operating cash flow (CN¥867.54K) in capital expenditures (CN¥5.41 Million). Check 002750 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Capital reinvestment ratio of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2019. This chart tracks Kunming Longjin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore Kunming Longjin Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Kunming Longjin Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2011–2019)
Kunming Longjin Pharmaceutical Co Ltd capital reinvestment ratio by year from 2011 to 2019. For the full cash flow conversion analysis, see cash efficiency ratio of Kunming Longjin Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.75x | CN¥4.04 Million | CN¥7.07 Million | ▲ +257.1% |
| 2018 | 0.49x | CN¥31.70 Million | CN¥15.53 Million | ▲ +62.2% |
| 2017 | 0.30x | CN¥58.06 Million | CN¥17.54 Million | ▲ +33.7% |
| 2016 | 0.23x | CN¥104.24 Million | CN¥23.56 Million | ▼ -33.7% |
| 2015 | 0.34x | CN¥70.19 Million | CN¥23.93 Million | ▲ +29.5% |
| 2014 | 0.26x | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥75.90 Million | CN¥92.79 Million | — |